# DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Unpacking a 25.96% Potential Upside

- Link: https://www.directorstalkinterviews.com/dentsply-sirona-inc-xray-investor-outlook-unpacking-a-25-96-potential-upside/4121246050
- Published: 2026-03-24T11:18:36+00:00
- Author: Madison Wilson

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments
and supplies industry, is drawing attention with its substantial potential upside
of 25.96%. This potential growth, alongside a compelling dividend yield of 5.04%,
positions XRAY as an intriguing prospect for investors in the healthcare sector.

Headquartered in Charlotte, North Carolina, DENTSPLY SIRONA is a venerable institution
in dental solutions, tracing its roots back to 1877. The company operates across
four main segments: Connected Technology Solutions, Essential Dental Solutions, 
Orthodontic and Implant Solutions, and Wellspect Healthcare, each offering a diverse
range of products from dental imaging equipment to advanced irrigation systems for
urology and enterology.

Currently trading at $11.54, DENTSPLY SIRONA’s stock reflects a price change of 
0.59 (0.05%) with a 52-week range between $9.89 and $16.85. Despite the challenges
highlighted by a negative EPS of -3.00 and a concerning Return on Equity (ROE) of-
36.43%, the company shows promise in other areas. Revenue growth stands at a solid
6.20%, and the firm boasts a healthy free cash flow of $106.38 million. This financial
cushion supports its attractive dividend yield, complemented by a conservative payout
ratio of 28.83%.

Investors should note the stock’s technical indicators, which present a mixed picture.
The 50-day and 200-day moving averages are $12.61 and $13.18, respectively, indicating
a current price below these thresholds. Moreover, the Relative Strength Index (RSI)
at 24.19 suggests that the stock is oversold, potentially providing a buying opportunity
for those looking to capitalize on market corrections.

The forward P/E ratio of 7.41 adds another layer of interest, suggesting that XRAY
is trading at a valuation below the industry average, possibly reflecting the market’s
cautious outlook amid current performance metrics. However, the absence of a trailing
P/E and PEG ratio indicates challenges in evaluating the company’s historical earnings
performance.

Analyst sentiment for DENTSPLY SIRONA is cautiously optimistic, with 4 buy ratings,
12 hold ratings, and only 1 sell rating. The target price range of $12.00 to $18.00,
with an average target of $14.54, underscores the potential for appreciation from
its current price, reinforcing the 25.96% upside.

DENTSPLY SIRONA’s strategic focus on integrated dental solutions, combined with 
its legacy and innovation in healthcare consumables, offers a robust foundation 
for future growth. As the company navigates its financial challenges, investors 
should weigh the potential rewards against the inherent risks, particularly given
the technical indicators signaling possible undervaluation.

For individual investors considering an entry into the healthcare sector, DENTSPLY
SIRONA presents an intriguing case of potential growth matched with income stability
through dividends. As always, thorough due diligence and consideration of market
conditions are advised before making investment decisions.

Share on: